Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junichi Nishimura

Showing results (191-200 of 256) with videos related to

Pageof 26
Sort By:
Anticancer Research|December 30, 2023
Short-term Outcomes of Adjuvant Nivolumab After Neoadjuvant Chemotherapy in Patients With Resected Esophageal Squamous Cell CarcinomaTakahito Sugase, Takashi Kanemura, Tomohira Takeoka, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 4, 2015
[A case of pathological complete response with neoadjuvant XELOX chemotherapy for locally advanced rectal cancer]Tomohiro Kitahara, Ichiro Takemasa, Akira Inoue, et al.
Clinical Nutrition (Edinburgh, Scotland)|August 15, 2024
Clinical impact of postoperative changes in body composition on long-term outcomes in patients with esophageal cancerTomohira Takeoka, Takashi Kanemura, Takahito Sugase, et al.
Scientific Reports|June 21, 2020
Sanguisorba officinalis L. derived from herbal medicine prevents intestinal inflammation by inducing autophagy in macrophagesAsuka Yasueda, Hisako Kayama, Michiko Murohashi, et al.
Oncology|October 5, 2022
Recurrence Pattern Comparing Preoperative Chemoradiotherapy and Preoperative Chemotherapy with Docetaxel plus 5-Fluorouracil and Cisplatin for Advanced Esophageal CancerTakahito Sugase, Keijiro Sugimura, Takashi Kanemura, et al.
Langenbeck'S Archives of Surgery|October 8, 2024
The clinical significance of the lymph node ratio as a recurrence indicator in ampullary cancer after curative pancreaticoduodenectomyShinichiro Hasegawa, Hiroshi Wada, Masahiko Kubo, et al.
Endoscopy|July 30, 2016
Image quality of a novel light-emitting diode (LED)-illuminated colonoscopeSho Sasaki, Jun Nishikawa, Hideo Yanai, et al.
Surgery Today|June 30, 2025
Impact of prophylactic 5-hydroxytryptamine-3 receptor antagonist on postoperative nausea and vomiting in patients undergoing laparoscopic or robotic colorectal cancer surgery: a propensity score-matched analysisToshinori Sueda, Junichi Nishimura, Ai Yamamura, et al.
The Journal of Biological Chemistry|January 22, 2015
RFPL4A increases the G1 population and decreases sensitivity to chemotherapy in human colorectal cancer cellsAtsushi Naito, Hirofumi Yamamoto, Yoshinori Kagawa, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 6, 2024
Prognostic impact of dysphagia scores in patients with advanced resectable esophageal cancer who underwent radical esophagectomy after preoperative treatmentTakahito Sugase, Takashi Kanemura, Norihiro Matsuura, et al.
Pageof 26

Showing results (191-200 of 256) with videos related to

Sort By:
Pageof 26
Anticancer Research|December 30, 2023
Short-term Outcomes of Adjuvant Nivolumab After Neoadjuvant Chemotherapy in Patients With Resected Esophageal Squamous Cell CarcinomaTakahito Sugase, Takashi Kanemura, Tomohira Takeoka, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 4, 2015
[A case of pathological complete response with neoadjuvant XELOX chemotherapy for locally advanced rectal cancer]Tomohiro Kitahara, Ichiro Takemasa, Akira Inoue, et al.
Clinical Nutrition (Edinburgh, Scotland)|August 15, 2024
Clinical impact of postoperative changes in body composition on long-term outcomes in patients with esophageal cancerTomohira Takeoka, Takashi Kanemura, Takahito Sugase, et al.
Scientific Reports|June 21, 2020
Sanguisorba officinalis L. derived from herbal medicine prevents intestinal inflammation by inducing autophagy in macrophagesAsuka Yasueda, Hisako Kayama, Michiko Murohashi, et al.
Oncology|October 5, 2022
Recurrence Pattern Comparing Preoperative Chemoradiotherapy and Preoperative Chemotherapy with Docetaxel plus 5-Fluorouracil and Cisplatin for Advanced Esophageal CancerTakahito Sugase, Keijiro Sugimura, Takashi Kanemura, et al.
Langenbeck'S Archives of Surgery|October 8, 2024
The clinical significance of the lymph node ratio as a recurrence indicator in ampullary cancer after curative pancreaticoduodenectomyShinichiro Hasegawa, Hiroshi Wada, Masahiko Kubo, et al.
Endoscopy|July 30, 2016
Image quality of a novel light-emitting diode (LED)-illuminated colonoscopeSho Sasaki, Jun Nishikawa, Hideo Yanai, et al.
Surgery Today|June 30, 2025
Impact of prophylactic 5-hydroxytryptamine-3 receptor antagonist on postoperative nausea and vomiting in patients undergoing laparoscopic or robotic colorectal cancer surgery: a propensity score-matched analysisToshinori Sueda, Junichi Nishimura, Ai Yamamura, et al.
The Journal of Biological Chemistry|January 22, 2015
RFPL4A increases the G1 population and decreases sensitivity to chemotherapy in human colorectal cancer cellsAtsushi Naito, Hirofumi Yamamoto, Yoshinori Kagawa, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 6, 2024
Prognostic impact of dysphagia scores in patients with advanced resectable esophageal cancer who underwent radical esophagectomy after preoperative treatmentTakahito Sugase, Takashi Kanemura, Norihiro Matsuura, et al.
Pageof 26